Breast density, MR imaging biomarkers, and breast cancer risk

Jessica H. Porembka, Jingfei Ma, Huong T. Le-Petross

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Mammographic breast density and various breast MRI features are imaging biomarkers that can predict a woman's future risk of breast cancer. While mammographic density (MD) has been established as an independent risk factor for the development of breast cancer, MD assessment methods need to be accurate and reproducible for widespread clinical use in stratifying patients based on their risk. In addition, a number of breast MRI biomarkers using contrast-enhanced and noncontrast-enhanced techniques are also being investigated as risk predictors. The validation and standardization of these breast MRI biomarkers will be necessary for population-based clinical implementation of patient risk stratification, as well. This review provides an update on MD assessment methods, breast MRI biomarkers, and their ability to predict breast cancer risk.

Original languageEnglish (US)
Pages (from-to)1535-1542
Number of pages8
JournalBreast Journal
Issue number8
StatePublished - Aug 1 2020


  • biomarkers
  • breast MRI
  • breast density
  • risk assessment

ASJC Scopus subject areas

  • Internal Medicine
  • Surgery
  • Oncology


Dive into the research topics of 'Breast density, MR imaging biomarkers, and breast cancer risk'. Together they form a unique fingerprint.

Cite this